Community/Retail

Eli Lilly and Company recently announced positive late-stage results in its clinical trial testing a combination of its experimental breast cancer drug and another widely-used treatment.

The Walgreens Flu Index is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranking of those experiencing the highest incidences of influenza across the country.

Have you ever considered pursuing a PGY-2 pharmacy residency in critcal care?

The FDA has approved Newron Pharmaceutical’s Xadago (safinamide), an add-on treatment for patients with Parkinson’s disease.

An estimated 86 million Americans have prediabetes, and 90% of them don't know they have it.

Several public health and antismoking groups are urging the FDA to enforce more stringent regulations on the manufacturing of tobacco products by banning candy and fruit-flavored e-cigarettes and cigars.

Metformin saves lives

Working in sales was so appealing to Brad that he decided to start his own business as a manufacturing representative.

An interdisciplinary treatment modality is especially effective when treating patients with chronic pain.

Personalizing doses of warfarin through genetic testing helped reduce the risk of combined adverse events in patients undergoing elective orthopedic surgery, according to data presented at the American College of Cardiology's 66th Annual Scientific Session.

The American Society of Clinical Oncology (ASCO) released a clinical practice guideline on human papillomavirus (HPV) vaccination for the primary prevention of cervical cancer.

From now through May 6, Rite Aid associates chainwide will be raising money for their local Children's Miracle Network Hospital during the Company's annual Miracle Balloon campaign.

The American Heart Association (AHA) has published a new science advisory stating that there is not enough evidence to support the use of fish oil supplementation as a primary prevention of cardiovascular disease in the general population.

The antidote to stress is finding humor and counting our blessings.

Pharmacy school graduation is right around the corner, and it is definitely a time for celebration.

Although dolutegravir (DTG) is known for its high genetic barrier to resistance, its durability to maintain virologic suppression had not previously been evaluated.

A study led by UC Irvine and Duke University, presented at the 2017 American Academy of Pain Medicine meeting in Orlando, examined the association between opioid therapy and melanoma progression in patients diagnosed with the disease.

Patients who take long-acting opioids are more likely to experience chronic opioid use, a report published in the CDC’s Morbidity and Mortality Weekly Report has determined.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

A new study published in the Journal of the American Pharmacists Association analyzed the use of the “#pharmacist” tag on Instagram.

Publix Pharmacy and BayCare Health System have announced an exclusive collaboration to improve the delivery of health care to the residents of Hillsborough, Pasco, Pinellas, and Polk counties in Florida.

At the American Academy of Pain Medicine’s 2017 Annual Meeting, survey results were presented that revealed the implications of naloxone use in real-world experiences with the recently approved intranasal naloxone formulation.

Award Finalists and Attendees to Enjoy Entertainment by Craig Karges at the San Diego Zoo

CVS Health has announced that it will launch Reduced Rx, a prescription savings program that will offer discounts on certain medications through CVS Health's pharmacy benefits manager, CVS Caremark, directly to patients.

An investigational Ebola vaccine showed promising results in an early-stage study, in which an induced immune response persisted in adult participants for nearly 1 year after receiving the vaccination.

The FDA has issued a warning regarding the drug Viberzi (eluxadoline), which is used to treat irritable bowel syndrome with diarrhea (IBS-D).

Published data seem to support OTC access.

NSAIDs are included in the Beers criteria list as potentially inappropriate for older patients.

Merck has announced the FDA’s approval of Keytruda’s indication for treatment in classical Hodgkin lymphoma (cHL) patients.